Top
Summary
All studies
Mortality
Serious outcomes
Peer-reviewed
All outcomes

Feedback
 
Analgesics⏵
Antiandrogens⏵
Antihistamines⏵
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle⏵
Melatonin
Metformin
Minerals⏵
Monoclonals⏵
Mpro inhibitors⏵
Naso/orophar..⏵
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors⏵
Thermotherapy
Vitamins⏵
More⏵

Other
Feedback
Home
 
Top
..
All posaconazole studies
..
Feedback
Home
c19early.org COVID-19 treatment researchPosaconazolePosaconazole (more..)
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta
Home Adoption Other Treatments
@CovidAnalysis

Outcomes in COVID-19 posaconazole studies

Home
Post
Share
@CovidAnalysis
StudiesStudies
FeedbackFeedback
All studies   Mortality   Serious outcomes   Peer-reviewed   All outcomes  
0 0.5 1 1.5+ All studies -131% 1 249 Improvement, Studies, Patients Relative Risk Mortality -131% 1 249 Prophylaxis -131% 1 249 Posaconazole for COVID-19 c19early.org February 2025 Favorsposaconazole Favorscontrol
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ POSACOVID Prattes -131% 2.31 [1.78-3.00] death 60/83 52/166 Improvement, RR [CI] Treatment Control Tau​2​ = 0.00, I​2​ = 0.0%, p < 0.0001 Prophylaxis -131% 2.31 [1.78-3.00] 60/83 52/166 131% higher risk All studies -131% 2.31 [1.78-3.00] 60/83 52/166 131% higher risk 1 posaconazole COVID-19 study c19early.org February 2025 Tau​2​ = 0.00, I​2​ = 0.0%, p < 0.0001 Effect extraction pre-specified(most serious outcome) Favors posaconazole Favors control 0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ POSACOVID Prattes -131% 2.31 [1.78-3.00] 60/83 52/166 Improvement, RR [CI] Treatment Control Tau​2​ = 0.00, I​2​ = 0.0%, p < 0.0001 Prophylaxis -131% 2.31 [1.78-3.00] 60/83 52/166 131% higher risk All studies -131% 2.31 [1.78-3.00] 60/83 52/166 131% higher risk 1 posaconazole COVID-19 mortality result c19early.org February 2025 Tau​2​ = 0.00, I​2​ = 0.0%, p < 0.0001 Favors posaconazole Favors control 0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ POSACOVID Prattes -131% 2.31 [1.78-3.00] death 60/83 52/166 Improvement, RR [CI] Treatment Control Tau​2​ = 0.00, I​2​ = 0.0%, p < 0.0001 Prophylaxis -131% 2.31 [1.78-3.00] 60/83 52/166 131% higher risk All studies -131% 2.31 [1.78-3.00] 60/83 52/166 131% higher risk 1 posaconazole COVID-19 serious outcome c19early.org February 2025 Tau​2​ = 0.00, I​2​ = 0.0%, p < 0.0001 Effect extraction pre-specified(most serious outcome) Favors posaconazole Favors control 0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ POSACOVID Prattes -131% 2.31 [1.78-3.00] death 60/83 52/166 Improvement, RR [CI] Treatment Control Tau​2​ = 0.00, I​2​ = 0.0%, p < 0.0001 Prophylaxis -131% 2.31 [1.78-3.00] 60/83 52/166 131% higher risk All studies -131% 2.31 [1.78-3.00] 60/83 52/166 131% higher risk 1 posaconazole COVID-19 peer reviewed studies c19early.org February 2025 Tau​2​ = 0.00, I​2​ = 0.0%, p < 0.0001 Effect extraction pre-specified(most serious outcome) Favors posaconazole Favors control 0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ POSACOVID Prattes -131% 2.31 [1.78-3.00] death 60/83 52/166 Improvement, RR [CI] Treatment Control POSACOVID Prattes 54% 0.46 [0.08-2.82] misc. 83 (n) 83 (n) POSACOVID Prattes 80% 0.20 [0.06-0.65] misc. 83 (n) 83 (n) POSACOVID Prattes -25% 1.25 [0.26-5.88] misc. 83 (n) 83 (n) Posaconazole COVID-19 outcomes c19early.org February 2025 Favors posaconazole Favors control
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Thanks for your feedback! Please search before submitting papers and note that studies are listed under the date they were first available, which may be the date of an earlier preprint.
Submit    
Post
Share
@CovidAnalysis
FAQ
Public domain CC0 1.0